Physician

John T Pajka, MD

According to 2025 Medicare claims, John Pajka, MD (NPI: 1861469108) practices ophthalmology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is PAJKA EYE CENTER INC (NPI: 1831167097; TIN: 341146550) and primary practice location at 45805-2764.

Pajka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 661 traditional Medicare patients, billed 11,158 HCPCS/CPT codes, and received $374,283 in Medicare payments. The top billing code was 66821 (Removal of recurring cataract in lens capsule using a laser). Part D data shows 1,902 prescription claims across 795 beneficiaries totaling $93,615 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). DME data shows 30 claims. Open Payments data shows 2 records totaling $23. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $788,064 to $374,283. Similarly, Part D prescription costs have fallen sharply in recent years, from $454,350 to $93,615. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,852	21,348	$788,064
2016	2,008	24,978	$845,839
2017	1,901	28,613	$888,805
2018	1,670	24,623	$741,460
2019	1,507	23,652	$808,403
2020	1,062	19,891	$595,559
2021	1,087	22,508	$654,261
2022	875	18,855	$515,790
2023	661	13,047	$380,093
2024	661	11,158	$374,283

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,395	5,397	$454,350
2016	1,431	4,961	$365,023
2017	1,464	4,302	$283,620
2018	1,366	4,211	$277,142
2019	1,395	4,356	$253,931
2020	1,233	3,628	$207,381
2021	1,369	3,753	$221,176
2022	1,224	3,120	$175,268
2023	837	2,187	$139,282
2024	795	1,902	$93,615

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	323	326	$20,626
2016	340	344	$20,666
2017	271	274	$16,810
2018	206	206	$11,336
2019	187	187	$11,069
2020	88	90	$6,391
2021	74	75	$4,357
2022	39	39	$2,339
2023	37	37	$2,580
2024	30	30	$2,026

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66821	Removal of recurring cataract in lens capsule using a laser	124	154	$231
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	370	370	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	134	148	$88
92136	Measurement of corneal curvature and depth of eye	362	582	$27
66984	Removal of cataract with insertion of prosthetic lens	345	9,013	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	825	34,574	$51,169
Moxifloxacin	Moxifloxacin Hcl	585	9,809	$20,633
Timolol Maleate	Timolol Maleate	156	9,257	$1,081
Latanoprost	Latanoprost	134	5,867	$1,010
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	29	2,167	$617

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	14	14	$1,083
V2020	Frames, purchases	N	16	16	$943

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$23	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$17,450,991	Midmark Corporation

Explore More Providers

FAQ

What Medicare data is available for John T. Pajka, MD?

Tedicare shows public-source Medicare data for John T. Pajka, MD (NPI 1861469108), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John T. Pajka, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John T. Pajka, MD?

John T. Pajka, MD is linked to PAJKA EYE CENTER INC (billing NPI 1831167097) in the available physician profile data.

Does John T. Pajka, MD have Open Payments data?

John T. Pajka, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.